1 pleasing clients at a molecular and cellular level august 7, 2015

1

PLEASING CLIENTS AT A MOLECULAR AND CELLULAR LEVEL

AUGUST 7, 2015

We live in a society exquisitely dependent on science and technology, in which hardly anyone knows anything about science and technology.

– Carl Sagan (1990)

3

TOPICS FOR DISCUSSION

Pace of life sciences1

Demands of the domain2

Multi-faceted and interdisciplinary business of science3

Focus on the customer: PDS in biotech4

Industry challenges & beyond5

4

SCIENCE DOMAIN: CHAOS & CHANGE

Science TechnologyHypotheses

ThroughputAnalyses

Conclusions

Ideas

Experiments

Data

Algorithms

MethodsAnd everyone is going through the process differently…

Models

Data Management

5

• Improvements in technology• Increase in amount of data• Development of algorithms

EVOLVING WITH THE PROCESS

Sample handling

Sample processing

Data storage

Data analysis

6

DURATION 10+ YEARS

TECHNOLOGY IS RACING FORWARD, BUT DRUG DEVELOPMENT CYCLE IS LONG

LEAD IDENTIFICATION

PRE-CLINICAL CLINICAL TRIALS

PHASE I PHASE II PHASE III

FDA REVIEW

3-6 YRS 6-7 YRS 1-2 YRS

MANY COMPOUNDS

250 COMPOUNDS

20-100 VOLUNTEERS

100-500 VOLUNTEERS

1,000-5,000 VOLUNTEERS

ONE APPROVED

DRUG

? YRS

TARGET ID &

VALIDATION

Genomics ProteomicsTranscriptomics Epigenomics

ChemistryMetabolomicsToxicity

And all that data has to be “handled”!

7

DURATION >10 YEARS

TECHNOLOGY IS RACING FORWARD, BUT CYCLE OF DRUG DEVELOPMENT IS LONG

LEAD IDENTIFICATION

PRE-CLINICAL CLINICAL TRIALS

PHASE I PHASE II PHASE III

FDA REVIEW

3-6 YRS 6-7 YRS 1-2 YRS

MANY COMPOUNDS

250 COMPOUNDS

20-100 VOLUNTEERS

100-500 VOLUNTEERS

1,000-5,000 VOLUNTEERS

ONE APPROVED

DRUG

? YRS

TARGET ID &

VALIDATION

Genomics ProteomicsTranscriptomics Epigenomics

ChemistryMetabolomicsToxicity

LEAD IDENTIFICATION

PRE-CLINICAL

3-6 YRS

MANY COMPOUNDS

250 COMPOUNDS

? YRS

TARGET ID &

VALIDATION

The greatest improvement to this cycle’s efficiency can be achieved

before the clinical phase

8

THE LIFE SCIENCES MILIEU

ChemistryEngineering

Regulatory

ClinicalAnimal Sciences

Biology

Informatics

FinanceOperations

IT

Legal

9

• Scientists and their habits• Reconciling business & science• Need someone to:

• Keep everyone focused• Suggest methods• Make workflows easy• Do it fast!

FROM SPREADSHEETS TO SYSTEMS: GETTING USERS ONBOARD

10

FOCUS ON THE CUSTOMER: DELIVERING ON THE PROMISE OF PDS

DirectionIdentify direction of the business

ScienceNovel technologies speed up the science

TechnologiesBring novel technologies to the business

BusinessScience drives business forward

11

SYSTEM TO ACCELERATE & OPTIMIZE DRUG DESIGN

https://www.youtube.com/watch?v=HjB536Glvpw

12

• Covers the process

• Open for integration

• With scientific context

• Allows integrated questions to be posed

A PRODUCT: DRUG DESIGN STUDIO

13

SYSTEM TO ACCELERATE & OPTIMIZE DRUG DESIGN

https://www.youtube.com/watch?v=vR3nauEkiuI

14

For specific business need

To be used across disciplines

With best scientific practices

AT THE END OF THE DAY: PRODUCT BUILT

1

2

3

We have software that captures & searches data.The Question is “What’s next?”

15

ONE STEP BEYOND

http://telemedicina.med.muni.cz/

16

SOLUTIONS FOR THE BIOTECH BUSINESS

CLIENTWhat do I do with the petabytes of

chemistry, biology, modeling, in-vivo, clinical data?

Provide system for data tracking & integration

How do I search it?Develop search algorithms that allow

omni-directional information flow across disciplines

What can I do with it? Develop analysis algorithms and visualization tools

EPAM

17

EXAMPLE: ELECTRONIC NOTEBOOK

• GOOD:

• Searchable• Achievable

• BAD:

• Organization• Data extraction • Visualization

• Need: Different notebooks for different disciplines (modular) with common back end and visualization layer

Biologists

Chemists

Informaticists

Clinicians

Animal Scientists

18

Onsite team must speak client’s language

TO ACHIEVE SUCCESS WITH CUSTOMER, REMEMBER:

Business Technology

Science

EPAM Team

19

THANKS TO

Thank You!

20